NDC 69152-1213

Cantharis 6C

Cantharis

Cantharis 6C is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Paramesh Banerji Life Sciences Llc. The primary component is Lytta Vesicatoria.

Product ID69152-1213_319e1d98-3b6a-6af4-e054-00144ff8d46c
NDC69152-1213
Product TypeHuman Otc Drug
Proprietary NameCantharis 6C
Generic NameCantharis
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-06-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameParamesh Banerji Life Sciences LLC
Substance NameLYTTA VESICATORIA
Active Ingredient Strength6 [hp_C]/1
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 69152-1213-1

96 PELLET in 1 BOTTLE (69152-1213-1)
Marketing Start Date2015-06-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69152-1213-1 [69152121301]

Cantharis 6C PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-06-03
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LYTTA VESICATORIA6 [hp_C]/1

OpenFDA Data

SPL SET ID:1798d1da-55ad-4588-e054-00144ff88e88
Manufacturer
UNII

NDC Crossover Matching brand name "Cantharis 6C" or generic name "Cantharis"

NDCBrand NameGeneric Name
69152-1213Cantharis 6CCantharis
76472-4010Cantharis 6cLYTTA VESICATORIA
0360-0093CANTHARISCANTHARIS
0360-0094CANTHARISCANTHARIS
15631-0105CANTHARISCANTHARIS
15631-0552CANTHARISCANTHARIS
15631-2311CANTHARISCANTHARIS
53645-1660CantharisCantharis
60512-9151CANTHARISCANTHARIS
63083-7111CantharisCantharis
69152-1015Cantharis 200CCantharis

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.